Clinical Trial Update: Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial aims to identify biomarkers that predict the effectiveness of adjuvant letrozole in postmenopausal breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: Institut fuer Frauengesundheit | Conditions: is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. | Phase 4 | Status: UNKNOWN